Г. Л. Игнатова

745 total citations
79 papers, 211 citations indexed

About

Г. Л. Игнатова is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Emergency Medical Services. According to data from OpenAlex, Г. Л. Игнатова has authored 79 papers receiving a total of 211 indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Pulmonary and Respiratory Medicine, 32 papers in Epidemiology and 23 papers in Emergency Medical Services. Recurrent topics in Г. Л. Игнатова's work include Chronic Obstructive Pulmonary Disease (COPD) Research (29 papers), Pneumonia and Respiratory Infections (27 papers) and Pediatric health and respiratory diseases (23 papers). Г. Л. Игнатова is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (29 papers), Pneumonia and Respiratory Infections (27 papers) and Pediatric health and respiratory diseases (23 papers). Г. Л. Игнатова collaborates with scholars based in Russia, United States and India. Г. Л. Игнатова's co-authors include С. Н. Авдеев, А. S. Belevskiy, И. В. Демко, Н. И. Брико, М. П. Костинов, О. В. Ковалишена, И. В. Лещенко, А. A. Vizel, Ovcharenko Si and Sidorenko Sv and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Vaccines.

In The Last Decade

Г. Л. Игнатова

56 papers receiving 184 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Г. Л. Игнатова Russia	7	119	72	35	29	22	79	211
Katy C. Norman United States	6	55 0.5×	211 2.9×	43 1.2×	44 1.5×	37 1.7×	7	327
Arnoldo Quezada Chile	9	48 0.4×	45 0.6×	15 0.4×	19 0.7×	34 1.5×	21	192
Tamara Mitchell United Kingdom	4	72 0.6×	10 0.1×	10 0.3×	6 0.2×	16 0.7×	6	154
Shaheen India	4	31 0.3×	39 0.5×	117 3.3×	50 1.7×	24 1.1×	7	198
Vojko Berce Slovenia	8	38 0.3×	106 1.5×	67 1.9×	10 0.3×	7 0.3×	23	215
Deborah Howarth United Kingdom	4	69 0.6×	29 0.4×	8 0.2×	10 0.3×	22 1.0×	6	122
Rachele Invernizzi United Kingdom	6	66 0.6×	157 2.2×	39 1.1×	45 1.6×	26 1.2×	10	286
Paraskevi Maggina Greece	7	138 1.2×	115 1.6×	82 2.3×	40 1.4×	28 1.3×	14	266
Antonio Marseglia Italy	8	46 0.4×	41 0.6×	10 0.3×	7 0.2×	23 1.0×	14	256
G. Daniel Brooks United States	4	110 0.9×	127 1.8×	193 5.5×	52 1.8×	21 1.0×	5	259

Countries citing papers authored by Г. Л. Игнатова

Since Specialization

Citations

This map shows the geographic impact of Г. Л. Игнатова's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Г. Л. Игнатова with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Г. Л. Игнатова more than expected).

Fields of papers citing papers by Г. Л. Игнатова

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Г. Л. Игнатова. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Г. Л. Игнатова. The network helps show where Г. Л. Игнатова may publish in the future.

Co-authorship network of co-authors of Г. Л. Игнатова

This figure shows the co-authorship network connecting the top 25 collaborators of Г. Л. Игнатова. A scholar is included among the top collaborators of Г. Л. Игнатова based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Г. Л. Игнатова. Г. Л. Игнатова is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Игнатова, Г. Л., et al.. (2025). 10-Year Effects of the 13-Valent Pneumococcal Conjugate Vaccine in Patients with Chronic Obstructive Pulmonary Disease and Stable Angina Pectoris. Vaccines. 13(10). 1000–1000.

2.

Айсанов, З. Р., et al.. (2024). Burden and management of severe asthma in Russia: results from international observational study. Terapevticheskii arkhiv. 96(3). 212–217.

3.

Игнатова, Г. Л., et al.. (2024). Effect of ATIC, ADA, ITPA, and AMPD1 gene polymorphisms on the efficacy of methotrexate in rheumatoid arthritis. 4–13.

4.

Игнатова, Г. Л., et al.. (2024). The use of exogenous surfactant in pulmonological practice. Meditsinskiy sovet = Medical Council. 41–48.

5.

Игнатова, Г. Л., et al.. (2024). The effectiveness of early administration of antifibrotic therapy as a reflection of properly organized medical care for patients with progressive pulmonary fibrosis. PULMONOLOGIYA. 34(1). 115–120.

6.

Fomina, Daria, et al.. (2024). Efficacy of benralizumab in severe eosinophilic asthma: results of a real clinical practice prospective study BEST in Russia. PULMONOLOGIYA. 34(3). 441–453.

7.

Чучалин, А. Г., et al.. (2023). Efficacy and safety of bovhyaluronidase azoximer (Longidase) in patients with post-COVID syndrome: results of an open, prospective, controlled, comparative, multicenter clinical trial DISSOLVE. PULMONOLOGIYA. 33(1). 52–63. 1 indexed citations

8.

Авдеев, С. Н., З. Р. Айсанов, А. S. Belevskiy, et al.. (2023). Inhaled corticosteroids administration/withdrawal as a therapeutic continuum for patients with chronic obstructive pulmonary disease in real clinical practice. PULMONOLOGIYA. 33(1). 109–118. 2 indexed citations

9.

Авдеев, С. Н., З. Р. Айсанов, А. S. Belevskiy, et al.. (2023). Inhaled corticosteroids administration/withdrawal as a therapeutic continuum for patients with chronic obstructive pulmonary disease in real clinical practice. PULMONOLOGIYA. 33(1). 109–118. 1 indexed citations

10.

Игнатова, Г. Л., et al.. (2023). Evaluation of the influence of polymorphisms of the transporter genes (RFC1, MDR1) and GGH on the efficacy of methotrexate in rheumatoid arthritis. SHILAP Revista de lepidopterología. 17(4). 28–34.

11.

Fomina, Daria, et al.. (2023). Efficacy of benralizumab in severe eosinophilic asthma: an interim analysis of a real clinical practice prospective study BEST in Russia. PULMONOLOGIYA. 33(3). 374–385. 1 indexed citations

12.

Vizel, А. A., et al.. (2022). Olokizumab reduces the risks of death in hospitalized patients with moderate and severe COVID-19. 11(4). 8–18.

13.

Авдеев, С. Н., et al.. (2022). Overuse of short-acting β2 -agonists in the Russian population with asthma: the persisting threat. PULMONOLOGIYA. 32(5). 661–669. 1 indexed citations

14.

Игнатова, Г. Л., et al.. (2020). Experience of using dupilumab in the treatment of severe asthma. SHILAP Revista de lepidopterología. 92(8). 95–99. 1 indexed citations

15.

Игнатова, Г. Л., et al.. (2017). Impact of vaccination on the course of bronchial and systemic inflammation in patients with COPD and CHD. Terapevticheskii arkhiv. 89(3). 29–33. 3 indexed citations

16.

Игнатова, Г. Л., et al.. (2017). Epidemiological characteristics of chronic respiratory diseases in patients vaccinated against pneumococcal infection. PULMONOLOGIYA. 27(3). 376–383. 5 indexed citations

17.

Игнатова, Г. Л., et al.. (2017). Clinical and Economic Efficiency of Vaccination in a Pneumococcal 13-Valent Conjugate Vaccine in Patients with Chronic Bronchitis at a Young Age. Epidemiology and Vaccinal Prevention. 16(2). 17–22. 2 indexed citations

18.

Игнатова, Г. Л., et al.. (2014). Клиническая эффективность вакцинации конъюгированной пневмококковой вакциной пациентов с хронической бронхолегочной патологией в Городском пульмонологическом центре Челябинска. 38–42. 1 indexed citations

19.

Игнатова, Г. Л., et al.. (2013). Clinical efficacy of vaccination of patients with chronic lung diseases with conjugated pneumococcal vaccine in Chelyabinsk pulmonological centre. PULMONOLOGIYA. 38–42. 2 indexed citations

20.

Игнатова, Г. Л., et al.. (2007). Preventive and therapeutic use of pneumococcal vaccine in industrial workers with chronic pulmonary diseases. PULMONOLOGIYA. 81–86.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact